IL246833A0
(en )
2016-08-31
Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA41265A
(en )
2017-10-31
COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS.
DK3119397T3
(en )
2022-03-28
Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
HRP20181698T1
(en )
2018-12-28
2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
DK3102213T3
(en )
2020-05-04
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
BR112016021012A2
(en )
2018-08-07
pharmaceutical compositions of therapeutically active compounds.
DK3882250T3
(en )
2023-05-22
TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
HRP20181332T1
(en )
2018-10-19
Benzimidazole derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA54716A
(en )
2021-11-17
REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
GB201411241D0
(en )
2014-08-06
Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
BR112017013012A2
(en )
2018-06-26
indenyl compounds, pharmaceutical compositions and medical uses thereof
DK3313370T3
(en )
2021-03-29
Ophthalmological pharmaceutical composition
DE112015002229A5
(en )
2017-06-29
Formulations for the treatment of hyperthyroidism
MA47193A
(en )
2019-11-13
SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE
HUP1600415A2
(en )
2018-01-29
Pimavanserin salts for the manufacture of pharmaceutical formulations
DK3423081T3
(en )
2021-10-18
COMPOSITIONS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASE
BR112016026443A2
(en )
2017-08-15
deuterated heterocyclic compounds, their uses, and pharmaceutical composition
HUP1400520A2
(en )
2016-05-30
Laquinimod salts useful for the preparation of pharmaceutical compositions
ES1135060Y
(en )
2015-03-20
"PLOWED"